News Blog

Ron Davis Update

“We are doing everything we can to continue progress on Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) during this time when we can’t go into the lab. This is a photo of me on a zoom conference call with doctors and researchers from across the country and Europe planning for a test of a new…

Read More

A Story of Hope from a Swedish Family Touched by ME / CFS

Today we’d like to share a story of hope from a Swedish family that has been devastated by ME / CFS. Sanna is a mother of four, and her 14-year old daughter Sara was stricken with ME / CFS in 2018. Since then, Sara has been severely afflicted. This march, Sara’s family is set to be featured on the…

Read More

A timely message from Ronald Tompkins, MD, ScD, Chief Medical Officer of Open Medicine Foundation

I want to speak directly to those suffering from ME  /CFS, who are trying to cope at this moment, with the international COVID-19 pandemic response. We have all been inundated by the usual and expected advisories that have conveyed the intended influence for otherwise healthy citizens to listen and appropriately deal with this crisis. The…

Read More

A message from Linda Tannenbaum regarding COVID-19

I know this is an especially stressful and uncertain time for patients and their families due to the coronavirus, and I am sending you all my strength and support. I have seen so many examples over the years of how resilient and compassionate this community is, and I trust we will come through this newest challenge…

Read More

PhD student joins the ME / CFS research team at Uppsala University, Sweden

“It’s of tremendous value to the ME / CFS research field to have a PhD student get involved in a topic like ME / CFS. They can dedicate 100% of their time. They really own the project and drive it. It’s what the field of ME / CFS needs.”  – Dr. Jonas Bergquist, MD, PhD OMF is proud to announce that…

Read More

A message from Ronald Tompkins, MD, ScD, Chief Medical Officer of Open Medicine Foundation

“It’s an honor to share a new multidisciplinary research article prepared by our colleagues and friends on the OMF Scientific Advisory Board, Dan Peterson, and Maureen Hanson. While not an OMF-funded project, this study exemplifies the rigorous research conducted by OMF and our associates. It is impossible to overstate the significance of getting an ME / CFS…

Read More

A Moment of Gratitude

Today, we want to extend a special thanks to OMF Ambassador Karin Alvtegen, one of Scandinavia’s most widely read and appreciated authors.Karin’s post on her Facebook page about her ongoing battle with ME / CFS has already raised more than $4,500 for OMF to support groundbreaking ME / CFS research! Karin has been sharing her Myalgic Encephalomyelitis / Chronic…

Read More

OMF Welcomes Alain Moreau, PhD, to our Scientific Advisory Board

Dr. Alain Moreau joins the OMF Scientific Advisory Board OMF is honored to welcome Canadian researcher, Dr. Alain Moreau, to our Scientific Advisory Board (SAB,) which is directed by Ronald W. Davis. PhD. “I initially decided to invite Dr. Moreau to join our ME / CFS Working Group because he demonstrated that he could take multiple novel…

Read More

OMF adds Ronald Tompkins, MD, ScD as ‘Chief Medical Officer’

In my role as Founder & CEO/President, and in partnership with our Scientific Advisory Board Director, Ronald W. Davis, PhD, I am thrilled to announce that Ronald Tompkins, MD, ScD has accepted the position of Chief Medical Officer of Open Medicine Foundation. The role of the Chief Medical Officer will be to facilitate communication between…

Read More

Stanford Research Update from Ronald W. Davis, PhD.

A Message To You From Ronald W. Davis, PhD Dr. Ron Davis, OMF Scientific Advisory Board Director and Director of the OMF-funded ME / CFS Collaborative Research Center at Stanford University, has a message of hope for the entire Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) community. Dr. Davis and his team at Stanford are continuing to expand…

Read More

Stay Informed

Be the first to hear our research news.

Subscribe Now.

No thanks